GENPHARM
GenericsGENPHARM is a generic drug manufacturer focused on Cardiovascular.
GENPHARM's Key Drugs
GENPHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
GENPHARM's Recent FDA Approvals
New NDA/BLA approvals for GENPHARM over the last two years — novel drugs only, excluding generics and label supplements.
GENPHARM's Therapeutic Areas
GENPHARM's approved drugs and pipeline span 1 therapeutic area, led by Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
GENPHARM's Top Competitors
GENPHARM's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
GENPHARM Pipeline Snapshot
Active clinical trials for GENPHARM across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1997-08-19
- Latest
- 2007-07-09
- Applications
- 4